Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced a new partnership with recently drafted NFL cornerback Kelee Ringo and his ...
WHAT: Grammy Award-Winning Artist and Breast Cancer Survivor Sheryl Crow is a staunch advocate of routine health screenings, including mammograms, as ...
In the U.S., COVID-19 has resulted in a projected delay of more than 22 million screening tests for cancer and a 20% reduction in oncology visits...
WHAT: Research has shown that Black women are almost 40 percent more likely to die from breast cancer than non-Hispanic white women.1 Hologic's...
WHAT: At the start of the COVID-19 pandemic, many health officials, professional societies and patient advocacy groups released guidance urging women ...
WHO: Hologic, Inc. (Nasdaq: HOLX), is the maker of the Genius™ 3D Mammography™ exam, the only mammogram clinically proven to detect 20 to 65 percent...
WHO: Hologic, Inc. (Nasdaq: HOLX), is the world leader in breast cancer screening technology and the maker of the Genius™ 3D Mammography™ exam, the...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 16th Annual Global Healthcare Conference in New...
Hologic, Inc. (Nasdaq: HOLX), a pioneer in cervical cancer screening, commends the United States Preventive Services Task Force (USPSTF) for...
Hologic, Inc. (Nasdaq: HOLX) announced today the U.S. launch of its new Fluent™ fluid management system, featuring innovations designed to provide...
Hologic, Inc. (Nasdaq: HOLX) today announced completion of an agreement between its Cynosure division and Porter Instrument, a business unit of...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Canaccord Genuity 38th Annual Growth Conference in New York, NY on...
Hologic, Inc. (Nasdaq: HOLX) announced today that it has received FDA clearance for its Group B Streptococcus (GBS) assay on the Panther Fusion®...
Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal third quarter ended June 30, 2018. "We posted good...
Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today it has completed the acquisition of Faxitron Bioptics, a...
Hologic, Inc. (Nasdaq: HOLX) announced today that Chief Financial Officer (CFO) Bob McMahon is leaving the Company to become the CFO of Agilent...
Hologic, Inc. (Nasdaq: HOLX) announced today that an Administrative Law Judge of the U.S. International Trade Commission (ITC) has issued a favorable ...
Hologic, Inc. (Nasdaq: HOLX) announced today that a jury in the U.S. District Court for the District of Delaware awarded Hologic $4.8 million in...
Hologic, Inc. (NASDAQ: HOLX) announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access...
Hologic's (Nasdaq: HOLX) Cynosure division announced today the North American launch of TempSure™ Vitalia, an FDA-cleared and Health Canada-approved...
Hologic, Inc. (Nasdaq: HOLX) announced today that its Panther Fusion® MRSA assay has received CE-mark in Europe. This assay, the latest in a growing...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2018 on Tuesday, ...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Jefferies Global Healthcare...
Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal second quarter ended March 31, 2018. Revenue of $789.3...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.